𝔖 Bobbio Scriptorium
✦   LIBER   ✦

CD8+ T cells specific for β cells encounter their cognate antigens in the islets of NOD mice

✍ Scribed by Shuguang Pang; Li Zhang; Haidong Wang; Zuoan Yi; Li Li; Ling Gao; Jiajun Zhao; Roland Tisch; Jonathan D. Katz; Bo Wang

Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
321 KB
Volume
39
Category
Article
ISSN
0014-2980

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Early intrahepatic antigen-specific rete
Early intrahepatic antigen-specific retention of naïve CD8+ T cells is predominantly ICAM-1/LFA-1 dependent in mice
✍ Patrick Bertolino; Arnhild Schrage; David G. Bowen; Katja Klugewitz; Saeed Ghani 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 309 KB

We have previously shown that naïve CD8+ T cells recognizing their cognate antigen within the liver are retained and undergo activation in situ, independent from lymphoid tissues. Intrahepatic primary T cell activation results in apoptosis and may play a crucial role in the ability of the liver to i

Localization of CD8+ cells specific for
Localization of CD8+ cells specific for hepatitis B virus surface protein in the liver of immunized mice
✍ Di Qu; Gibson Lanier; Zheng Hong Yuan; Yu Mei Wen; Colin R. Howard; Rafi Ahmed 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 310 KB

## Abstract DNA plasmids are potent inducers of long‐lasting antigen‐specific CTL responses. Little is known about the distribution of antigen‐specific CD8^+^ T cells in the lymphoid tissue and the non‐lymphoid tissue after DNA immunization. HBsAg‐specific CD8^+^ T cells in peripheral blood mononuc

Adoptive transfer of an anti-MART-127–35
Adoptive transfer of an anti-MART-127–35-specific CD8+ T cell clone leads to immunoselection of human melanoma antigen-loss variants in SCID mice
✍ Francesco Lozupone; Licia Rivoltini; Francesca Luciani; Massimo Venditti; Luana 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 491 KB

## Abstract The identification of appropriate mouse models could be useful in carefully evaluating the actual role of the __in vivo__ development of antigen‐loss variants during antigen‐specific vaccine therapy of human tumors. In this study we investigated the level of efficacy of a MART‐1/Melan‐A